As of September 2026, VanEck Biotech ETF is classified as halal.
HALAL
Is VanEck Biotech ETF Halal?
Shariah Compliance Analysis of BBH ETF
US Equity Health Care
Yes. As of September 2026, VanEck Biotech ETF (BBH) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. VanEck Biotech ETF passes Musaffa's business and financial screening criteria.
BBH was created on 2011-12-20 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 382.34m in AUM and 26 holdings. BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally.
VanEck Biotech ETF (BBH) Chart
Key Statistics of VanEck Biotech ETF (BBH)
Today's Open
-
AUM
-
Avg. Volume
-
Expense Ratio
-
P/E Ratio
-
P/B Ratio
-
Sector Exposure
Health Care
92.75%
Other
7.25%
FAQ's for VanEck Biotech ETF (BBH)
As of September 2026, VanEck Biotech ETF BBH is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes VanEck Biotech ETF using these criteria to determine its compliance status.
The Shariah compliance status of VanEck Biotech ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of VanEck Biotech ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.